DeviceTalks Weekly, powered by MassDevice
In this week’s DeviceTalks Weekly Podcast, our opening and closing keynote interviews focus on executives from companies at very different stages.
Manufacturing and sourcing
Skip Kiil took the helm of Smith+Nephew’s (NYSE:SNN) global orthopedics business to transform it. The company’s recent acquisition of Integra LifeSciences’ (NSDQ:IART) extremities business will further that mission. In our closing keynote conversation, Kiil updates us on the new technologies and tools that Smith+Nephew is rolling out to help orthopedic patients.
Kiil will hit upon Smith+Nephew’s:
- CORI Robotics surgical tools.
- Real Intelligence platform.
- Interest in Ambulatory Surgery Centers.
- Balance of outside of U.S. vs. U.S. business.
- Future plans for extremities.
Innovation and finance
Startup Rhaeos took home this year’s grand prize from the Medtech Innovator Global Competition at the Virtual Medtech Conference by AdvaMed. In our 0pening keynote, CEO Anna Lisa Somera tells us why she went all-in on developing a hydrocephalus wearable device that can help this suffering patient population.
Somera will discuss:
- Winning the global competition.
- The power of Rhaeous’ wearable technology.
- Medtech’s ability to help long-suffering patients.
- The startup’s fundraising plans.
Co-hosts Tom Salemi and Chris Newmarker will also review this week’s biggest stories on MassDevice, including former Medtronic CEO Omar Ishrak’s legacy, current Medtronic CEO Geoff Martha’s optimism, and Avail Medsystem’s $100 million plans to grow procedural telemedicine.
